Steve DeCherney MD MPH is Professor of Medicine and former Professor (Adjunct) of Business in the Kenan-Flagler School of Business, University of North Carolina. Steve is board certified in Internal Medicine and Endocrinology, Diabetes and Metabolism and was named as one of the Best Doctors in America.
Earlier in his career, Steve was CEO of Health Decisions Inc and is now a member of their Board of Directors. He served as President Global CRO at Quintiles Transnational Corporation. Steve serves on the Board of KNOW Bio and has many other business interests and serves on the Board of Directors of Robert F. Kennedy Human Rights. He also serves as a Trustee of the University of Delaware Research Foundation and is a Trustee of the Christiana Care Health System. He was an independent director of Theorem Clinical Research Company. Additionally, Steve was a Board Member of Symyx Corporation, also serving on their Audit Committee. Steve served as a Trustee of the William Harvey Research Foundation, of the Queen Mary Medical College, St. Barts and the London Hospitals, University of London. He was a senior advisor to the London Genetics Company, Member of the Farmer Food Share Board of Trustees and Chairman of their Finance Subcommittee.
Steve graduated from Columbia College of Columbia University, New York and in Medicine from Temple University, Philadelphia, He also earned an MPH, Healthcare Policy and Management, from Columbia University School of Public Health.
Health Decisions is a full-service CRO specializing in clinical studies of therapeutics for women’s health indications and studies of diagnostics for all therapeutic areas. Steve previously served as CEO and is currently a Member of the Board of Directors.
Quintiles Transnational (now IQVIA) is the largest pharmaceutical outsourcing services company in the United States. The company is committed to bringing clients the best in creative problem solving, enabling healthcare companies to innovate, maximize opportunities and drive forward human health.
University of Delaware Research Foundation supports high-quality engineering and scientific research projects, with grants given mainly in the fields of engineering and the natural and physical sciences.
The London School of Hygiene & Tropical Medicine is renowned for its research, postgraduate studies and continuing education in public and global health. With an annual research income of more than £140 million they are one of the highest-rated research institutions in the UK.
Chiltern, a leading global contract research organization acquired Theorem Clinical Research, strengthening its position as the largest mid-sized provider of comprehensive, clinical development services.
Symyx Corporation, is now part of Biovia, which provides a scientific environment for advanced chemical, biological and materials experiences to help science develop higher quality products faster and more cost effectively.
The William Harvery Research Institute - Barts and the London - aims to lead world-class research in cardiovascular, inflammatory and endocrine diseases.
London Genetics Limited is a commercial company created to facilitate and manage partnerships between the healthcare industry and London centres of excellence in genetics and genomics-based medical research.
Farmer Foodshare was established with the aim of making fresh, local food available to everyone in the community and to make sure that the farmers producing the food make a healthy living.
Robert F. Kennedy Human Rights, founded in 1968, is led by human rights activist and lawyer Kerry Kennedy and advocates for a more just and peaceful world. Working alongside local activists to ensure lasting positive change in governments and corporations, the RFK team includes leading attorneys, advocates, entrepreneurs and writers united by a commitment to social justice.
Christiana Care Health System is a not-for-profit health system that believes that the key to providing truly great health care is to partner with patients and their families, building a system of care that is effective, affordable and valuable to everyone.
